General form of registration statement for all companies including face-amount certificate companies

Note 14 - Research and Development Expenses

v3.24.3
Note 14 - Research and Development Expenses
9 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Notes to Financial Statements    
Research, Development, and Computer Software Disclosure [Text Block]

NOTE 14: RESEARCH AND DEVELOPMENT EXPENSES 

 

   

Three months ended

September 30,

   

Nine months ended

September 30,

 
   

2024

   

2023

   

2024

   

2023

 

Salary and employee benefits

  $ 711     $ 317     $ 1,154     $ 571  

Consultants and subcontractors

    100       25       177       48  

Depreciation

    4       -       8       -  

Clinical trials

    -       -       -       19  

Expenses - other

    63       50       178       74  

Total

  $ 878     $ 392     $ 1,517     $ 712  

 

NOTE 15: RESEARCH AND DEVELOPMENT EXPENSES

 

   

December 31

 
   

2023

   

2022

 
                 

Salary and employee benefits

  $ 527     $ 944  

Consultants and subcontractors

    99       152  

Depreciation and amortization

    -       14  

Clinical trials

    3       60  

Expenses - other

    112       129  
      741       1,299  

Less – grants received

    -       -  

Total

  $ 741     $ 1,299